Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas
Authors:
- 10 October 2004
- journal article
- research article
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 17 (3-6) , 296-302
Abstract
The objective of this study was to evaluate the potential of dynamic contrast-enhanced MRI for quantitative characterization of tumor microvessels and to assess the microvascular changes in response to isolated limb perfusion with TNF-α and melphalan. Dynamic contrast-enhanced MRI was performed in an experimental cancer model, using a macromolecular contrast medium, albumin-(Gd-DTPA)45. Small fragments of BN 175, a soft-tissue sarcoma, were implanted in 11 brown Norway (BN) rats. Animals were assigned randomly to a control (Haemaccel) or drug-treated group (TNF-α/melphalan). MRI was performed at baseline and 24 h after ILP. The transendothelial permeability (KPS) and the fractional plasma volume (fPV) were estimated from the kinetic analysis of MR data using a two-compartment bi-directional model. KPS and fPV decreased significantly in the drug-treated group compared to baseline (pPS post therapy was significantly lower (p<0.05) in the drug-treated group than in the control group. There was no significant difference in fPV between the drug-treated and the control group after therapy. Tumor microvascular changes in response to isolated limb perfusion can be determined after 24 h by dynamic contrast-enhanced MRI. The data obtained in this experimental model suggest possible applications in the clinical setting, using the appropriate MR contrast agents.Keywords
This publication has 37 references indexed in Scilit:
- Assessing tumor angiogenesis using macromolecular MR imaging contrast mediaJournal of Magnetic Resonance Imaging, 1997
- Physiologic measurements by contrast‐enhanced MR imaging: Expectations and limitationsJournal of Magnetic Resonance Imaging, 1997
- Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the ratBritish Journal of Surgery, 1996
- Isolated limb perfusion with TNFα and melphalan in a rat osteosarcoma model: a new anti-tumour approachEuropean Journal of Surgical Oncology, 1996
- Quantification of liver blood volume: comparison of ultra short ti inversion recovery echo planar imaging (ulstir‐epi), with dynamic 3d‐gradient recalled echo imagingMagnetic Resonance in Medicine, 1995
- Contrast-Enhanced Magnetic Resonance Imaging Estimation of Altered Capillary Permeability in Experimental Mammary Carcinomas After X-IrradiationInvestigative Radiology, 1994
- Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive techniqueMagnetic Resonance in Medicine, 1993
- Immunogenicity of Gadolinium-Based Contrast Agents for Magnetic Resonance ImagingInvestigative Radiology, 1991
- The efficacy of combined treatment with recombinant human tumor necrosis factor-α and 5-fluorouracil is dependent on the development of capillaries in tumorEuropean Journal of Cancer, 1990
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.Journal of Experimental Medicine, 1987